Benign metastasizing leiomyoma and lymphangioleiomyomatosis: sex-specific diseases?
Section snippets
Pathogenesis
The pathogenesis of BML remains controversial, despite the presumed etiology inherent in its name—uterine leiomyomata metastasizing to a distant site. There are three hypotheses to explain the mechanism of disease in BML that are discussed in the literature: metastatic uterine leiomyoma, metastatic uterine leiomyosarcoma, and multifocal leiomyoma growths.
Clinical characteristics
BML usually affects women who have undergone prior uterine surgery for leiomyomas [18] and appears several years after the surgery [7]. Patients are commonly asymptomatic at the radiographic presentation of pulmonary nodules; however, some symptoms such as cough, chest pain, and dyspnea have been reported [18]. BML should be considered in asymptomatic women with a history of uterine leiomyomas who present with multiple pulmonary nodules [18].
Radiologic findings
Pulmonary lesions often are incidental findings in a
Treatment of benign metastasizing leiomyoma
Pulmonary tumors in BML can be treated with bronchoscopic resection, conservative pulmonary surgery, and hormonal manipulation [2]. Surgical hormonal management can be accomplished with bilateral oophorectomy. Medical hormonal management includes the use of luteinizing hormone-releasing hormone analogue, tamoxifen, progesterone [2], and aromatase inhibitors [7].
Treatment results have had variable outcomes among patients. A woman with multiple pulmonary nodules who underwent a prior hysterectomy
Other unusual growth patterns of leiomyomas
BML is considered an unusual growth pattern of uterine leiomyomas. There are two other rare conditions that fall into this category and may have a similar pathogenesis: intravascular leiomyomatosis (IVL) and disseminated peritoneal leiomyomatosis (DPL) [16]. These conditions may all be part of a spectrum of benign smooth muscle tumors of the uterus, with an ordinary uterine leiomyoma at one end and BML at the other [15].
IVL (also called intravenous leiomyomatosis) is a rare tumor of the uterus,
Benign metastasizing leiomyoma and lymphangioleiomyomatosis
There are many similarities between BML and LAM, including smooth muscle proliferation, pulmonary location, female predominance, hormonal dependence as evidenced by progression during child-bearing years [37], and HMB-45 immunoreactivity [2]. Some authors suggest that these two diseases may be related or share a common histogenesis with perivascular mesenchymal cells. LAM is characterized by the disorderly proliferation of atypical smooth muscle cells along lymphatics, small airways, and blood
Lymphangioleiomyomatosis: clinical, radiographic, and pathologic features
LAM patients are usually women of reproductive age who present with a spontaneous pneumothorax, chylous pleural effusion, progressive exertional dyspnea [18], cough, or occasionally hemoptysis [32], [42]. A review of the literature indicates that the average age at onset of symptoms and age at diagnosis are in the early thirties and forties, respectively. The average interval between onset of symptoms and time of diagnosis is approximately 3 to 4 years [4]. LAM also has been reported to occur
Lymphangioleiomyomatosis and tuberous sclerosis complex
Two distinct types of LAM are reported in the literature: sporadic cases and those found in patients with tuberous sclerosis complex (TSC). TSC is an autosomal-dominant neurocutaneous disorder with variable penetrance caused by mutations in the TSC1 and TSC2 genes. Mutations in TSC2 have been isolated in patients with sporadic LAM and in patients with TSC and LAM [50].
Although the incidence and prevalence of sporadic LAM is unknown, it has been estimated by the LAM Foundation that there may be
Therapeutic options for lymphangioleiomyomatosis patients
Although the role of estrogens in LAM remains unclear, antiestrogen therapy has become the method of managing a patient with LAM. Tamoxifen, a partial estrogen receptor agonist, was used for many years but was reported to exacerbate disease in some women [45].
Most women with LAM have been put on some form of progesterone during the course of their disease. It is thought that progesterone down-regulates the estrogen receptor so that estrogens are less active. Progesterone can be given via
Hormonal features of benign metastasizing leiomyoma and lymphangioleiomyomatosis
The development of smooth muscle tumors is hormonally influenced, as evidenced by uterine leiomyomas developing after menarche, increasing in size during pregnancy, regressing after menopause, and shrinking after therapy with gonadotropin-releasing hormone antagonists [17], [26]. During the menstrual cycle, the mitotic count in leiomyomas is greater during the secretory phase and higher in younger women [26]. Ultrastructural analysis has shown that cells resembling fibroblasts develop after
References (74)
- et al.
Immunohistological detection of estrogen and progesterone receptors in multiple and well differentiated leiomyomatous lung tumors in women with uterine leiomyomas (so-called benign metastasizing leiomyomas). A report on 5 cases
Pathol Res Pract
(1996) - et al.
Benign metastasizing leiomyoma: a cytogenetically balanced but clonal disease
Hum Pathol
(2000) - et al.
Multiple pulmonary nodules in an asymptomatic patient
Chest
(1999) - et al.
Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy
Obstet Gynecol
(1997) - et al.
Metastasizing uterine leiomyoma. A case with cardiac and pulmonary metastasis
Pathol Res Pract
(1996) - et al.
Leiomyoma of the uterus with multiple extrauterine smooth muscle tumors: a case report suggesting multifocal origin
Hum Pathol
(1989) - et al.
Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors
J Thorac Cardiovasc Surg
(1996) Communications to the editor: natural decrease of benign metastasizing leiomyoma
Chest
(2000)- et al.
Remarkable and persistent shrinkage of uterine leiomyoma associated with interferon alpha treatment for hepatitis
Lancet
(1999) A 35-year-old woman with cough, dyspnea, and an abnormal chest radiograph
Chest
(1998)
Lymphangioleiomyomatosis and SZ alpha-1-antitrypsin deficiency: a unique combination?
Chest
Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis
Chest
Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis
Chest
Immunohistochemistry in diagnostic dermatopathology
Dermatol Clin
Pulmonary tuberous sclerosis
Chest
Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis
J Biol Chem
Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin
J Biol Chem
Lymphangioleiomyomatosis: a review
Chest
Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomyomatosis treated with medroxyprogesterone, oophorectomy and tamoxifen
Br J Dis Chest
Benign metastasizing leiomyoma of the lung: a case report
J Formos Med Assoc
Benign metastasizing leiomyoma with intracaval leiomyomatosis
Br J Radiol
Fine needle aspiration diagnosis of benign metastasizing leiomyoma of the lung. A case report
Acta Cytol
Benign metastasizing leiomyoma of the uterus. Histologic and immunohistochemical characterization of primary and metastatic lesions
Arch Pathol Lab Med
Natural decrease of benign metastasizing leiomyoma
Chest
Benign metastasizing leiomyoma in the lung
Radiographics
Intravenous leiomyomatosis of the uterus with multiple pulmonary metastases associated with large bullae-like cyst formation
Pathol Int
Pulmonary leiomyomatosis in women after hysterectomy for uterine myoma. Benign metastasizing leiomyoma?
Acta Chir Hung
Pulmonary benign metastasizing leiomyoma: response to treatment with goserelin
Thorax
Metastasizing fibroleiomyoma of the uterus. Report of a case and review of the literature
Am J Pathol
Intracardiac leiomyomatosis: case report and literature review
Arch Gynecol Obstet
Pathology and pathophysiology of uterine smooth-muscle tumors
Environ Health Perspect
Spontaneous regression of pulmonary leiomyomas during pregnancy
Cancer
Benign metastasizing leiomyoma: clinical, imaging, and pathologic correlation
Am J Roentgenol
Metastasizing leiomyoma of the uterus and hormonal manipulations. Case report
Br J Obstet Gynaecol
Leiomyomatous neoplasms of the lung: a clinical, histologic, and immunohistochemical study
Mod Pathol
Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasms
Am J Surg Pathol
Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases
Am J Surg Pathol
Cited by (38)
A deceptively alarming “balloon release”!
2024, Annales de PathologieBenign Metastasizing Leiomyoma
2016, Clinics in Chest MedicineCitation Excerpt :It has been postulated that BML cells originate from a single site.32 Although among uterine tumors BML has been mainly associated with leiomyomas,2 the type of leiomyomas is unclear (eg, mitotically active, cellular, hemorrhagic cellular, atypical, epithelioid, myxoid, vascular, lipoleiomyomas). Other types of smooth muscle tumors of the uterus that could be associated with BML are smooth muscle tumors of uncertain malignant potential, leiomyosarcomas, and endometrial stromal tumors.33,35,36
Benign metastasizing leiomyomatosis (BML): A rare cause of cavitary and cystic pulmonary nodules
2015, Respiratory Medicine Case ReportsReview of Thoracic Imaging Findings Unique to Women
2015, Canadian Association of Radiologists JournalCitation Excerpt :The surrounding lung parenchyma could be normal or show air trapping and septal thickening. Focal ground-glass opacities also may be seen, due to recurrent pulmonary hemorrhage [4,5]. Endometriosis represents ectopic endometrial cells outside of the uterus, which symptoms are associated with menstrual periodicity [6].
Novel hormone treatment of benign metastasizing leiomyoma: An analysis of five cases and literature review
2013, Fertility and SterilityCitation Excerpt :In one patient, histological diagnosis may have been associated with significant morbidity, given the close proximity of the lung nodules to the heart (case 1). Another case demonstrates the reported close pathogenesis between IVL and BML, as the patient presented with an IVC/cardiac tumor consistent with IVL as well as pulmonary lesions consistent with BML (5, 42, 43) (case 4). This case series suggests that hormone therapy may be used in the treatment of BML, specifically by employing synergistic combinations with individual dosing.